NASDAQ$BTTC

Black Titan Corp · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Headline financials

Total Revenue

$0.00

Previous: $83K-100.0%
EPS (adj)

-$2.29

Previous: -$2.20-4.1%
Capital Expenditures

$0.00

No prior period
Free Cash Flow

-$2.07M

No prior period
Net Income

-$2.09M

Previous: -$1.59M-32.0%
Operating Income

-$2.07M

Previous: -$1.59M-30.6%
Gross Profit

-$3K

Previous: -$441K+99.3%
Cash & Equivalents

$4.09M

Previous: $105K+3797.1%
Total Assets

$4.35M

Previous: $812K+435.7%
R&D Expense

$0.00

No prior period

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$0

Q2 2024-100%vs Q2 2023
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro